Cargando…
S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton
BACKGROUND: Deregulation of the phosphatidylinositol 3-kinases (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway plays a central role in tumor formation and progression, providing validated targets for cancer therapy. S9, a hybrid of α-methylene-γ-lactone and 2-phenyl indole compound, possesse...
Autores principales: | Zhang, Chao, Yang, Na, Yang, Chun-hao, Ding, Hua-sheng, Luo, Cheng, Zhang, Yu, Wu, Mao-jiang, Zhang, Xiong-wen, Shen, Xu, Jiang, Hua-liang, Meng, Ling-hua, Ding, Jian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654064/ https://www.ncbi.nlm.nih.gov/pubmed/19293927 http://dx.doi.org/10.1371/journal.pone.0004881 |
Ejemplares similares
-
Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway
por: Guo, Xiao-Hong, et al.
Publicado: (2021) -
Matrine exerts antitumor activity in cervical cancer by protective autophagy via the Akt/mTOR pathway in vitro and in vivo
por: Zhang, Fan, et al.
Publicado: (2022) -
Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR Pathway
por: Liu, Fangfang, et al.
Publicado: (2022) -
Anticancer Activity of New Na(I) Complex on Retinoblastoma Cells via Inhibiting PI3K/AKT/mTOR Pathway
por: Zhang, Jun, et al.
Publicado: (2021) -
Dieckol exerts anticancer activity in human osteosarcoma (MG-63) cells through the inhibition of PI3K/AKT/mTOR signaling pathway
por: Zhang, Shouqiang, et al.
Publicado: (2021)